FLNC and restrictive cardiomyopathy: With regard to different structural and functional molecular effect of FLNC mutations, the final clinical phenotype can result either from protein aggregation and defects of proteostasis (restrictive cardiomyopathy or myofibrillar myopathy), or from filamin insufficiency due to loss of function effects of mutation.